Background: Diagnosis of immediate drug hypersensitivity reactions (IDHRs) is based upon history taking, skin prick or intradermal tests and quantification of specific immunoglobulin E (IgE) antibodies. Unfortunately, this is often insufficient to correctly identify patients with IgE-mediated IDHRs and is impossible in the case of non-IgE-mediated IDHRs. Drug provocation tests (DPT) are considered the ‘gold standard' diagnostic but are not always possible, for ethical and practical reasons. Therefore, the validation of new cellular tests such as basophil activation testing (BAT) was necessary. This review focuses on the applications of BAT in IDHRs. Methods: A literature search was conducted, using the words basophil, flow cytometry, immediate drug allergy and drugs; this was complemented by the authors' own expertise. Results: BAT/HistaFlow® is a useful diagnostic tool in IDHRs, mainly used to diagnose allergy to neuromuscular blocking agents (NMBAs), antibiotics, nonsteroidal anti-inflammatory drugs (NSAIDs) and iodinated radiocontrast media. Its sensitivity varies between 50 and 60%, and specificity attains 80%, except for with quinolones and NSAIDs. Conclusions: The diagnostic utility of BAT (and to lesser extent HistaFlow) has been demonstrated and is mostly applied in IDHRs. However, larger-scale collaborative studies are necessary to optimize test protocols and validate the entry of BAT as a diagnostic instrument in drug allergy.

Keywords:
Basophil activation, Flow cytometry, HistaFlow®, Immunoglobulin E, Immediate drug allergy
1.
Knol EF, Mul FP, Jansen H, Calafat J, Roos D: Monitoring human basophil activation via CD63 monoclonal antibody 435. J Allergy Clin Immunol 1991;88:328-338.
2.
Ebo DG, Bridts CH, Hagendorens MM, Aerts NE, De Clerck LS, Stevens WJ: Basophil activation test by flow cytometry: present and future applications in allergology. Cytometry B Clin Cytom 2008;74:201-210.
3.
Sabato V, Verweij MM, Bridts CH, Levi-Schaffer F, Gibbs BF, De Clerck LS, Schiavino D, Ebo DG: CD300a is expressed on human basophils and seems to inhibit IgE/FcεRI-dependent anaphylactic degranulation. Cytometry B Clin Cytom 2012;82:132-138.
4.
Ebo DG, Dombrecht EJ, Bridts CH, Aerts NE, De Clerck LS, Stevens WJ: Combined analysis of intracellular signalling and immunophenotype of human peripheral blood basophils by flow cytometry: a proof of concept. Clin Exp Allergy 2007;37:1668-1675.
5.
Verweij MM, Sabato V, Nullens S, Bridts CH, De Clerck LS, Stevens WJ, Ebo DG: STAT5 in human basophils: IL-3 is required for its FcεRI-mediated phosphorylation. Cytometry B Clin Cytom 2012;82:101-106.
6.
Ebo DG, Bridts CH, Mertens CH, Hagendorens MM, Stevens WJ, De Clerck LS: Analyzing histamine release by flow cytometry (HistaFlow): a novel instrument to study the degranulation patterns of basophils. J Immunol Methods 2012;375:30-38.
7.
Bridts CH, Sabato V, Mertens C, Hagendorens MM, De Clerck LS, Ebo DG: Flow cytometric allergy diagnosis: basophil activation techniques. Methods Mol Biol 2014;1192:147-159.
8.
Abuaf N, Rajoely B, Ghazouani E, Levy DA, Pecquet C, Chabane H, Leynadier F: Validation of a flow cytometric assay detecting in vitro basophil activation for the diagnosis of muscle relaxant allergy. J Allergy Clin Immunol 1999;104(2 Pt 1):411-418.
9.
Monneret G, Benoit Y, Debard AL, Gutowski MC, Topenot I, Bienvenu J: Monitoring of basophil activation using CD63 and CCR3 in allergy to muscle relaxant drugs. Clin Immunol 2002;102:192-199.
10.
Sudheer PS, Hall JE, Read GF, Rowbottom AW, Williams PE: Flow cytometric investigation of peri-anaesthetic anaphylaxis using CD63 and CD203c. Anaesthesia 2005;60:251-256.
11.
Kvedariene V, Kamey S, Ryckwaert Y, Rongier M, Bousquet J, Demoly P, Arnoux B: Diagnosis of neuromuscular blocking agent hypersensitivity reactions using cytofluorimetric analysis of basophils. Allergy 2006;61:311-315.
12.
Ebo DG, Bridts CH, Hagendorens MM, Mertens CH, De Clerck LS, Stevens WJ: Flow-assisted diagnostic management of anaphylaxis from rocuronium bromide. Allergy 2006;61:935-939.
13.
Sainte-Laudy J, Orsel I: Interest of a new flow cytometric protocol applied to diagnosis and prevention of anaesthetic accidents induced by neuromuscular blockers. Rev Fr Allergol 2008;48:470-475.
14.
Leysen J, Bridts CH, De Clerck LS, Vercauteren M, Lambert J, Weyler JJ, Stevens WJ, Ebo DG: Allergy to rocuronium: from clinical suspicion to correct diagnosis. Allergy 2011;66:1014-1019.
15.
Hagau N, Gherman-Ionica N, Sfichi M, Petrisor C: Threshold for basophil activation test positivity in neuromuscular blocking agents hypersensitivity reactions. Allergy Asthma Clin Immunol 2013;9:42-49.
16.
Uyttebroek AP, Sabato V, Leysen J, Bridts CH, De Clerck LS, Ebo DG: Flowcytometric diagnosis of atracurium-induced anaphylaxis. Allergy 2014;69:1324-1332.
17.
Sanz ML, Gamboa PM, Antepara I, Uasuf C, Vila L, Garcia-Aviles C, Chazot M, De Weck AL: Flow cytometric basophil activation test by detection of CD63 expression in patients with immediate-type reactions to betalactam antibiotics. Clin Exp Allergy 2002;32:277-286.
18.
Gamboa PM, Garcia-Aviles MC, Urrutia I, Antepara I, Esparza R, Sanz ML: Basophil activation and sulfidoleukotriene production in patients with immediate allergy to betalactam antibiotics and negative skin tests. J Investig Allergol Clin Immunol 2004;14:278-283.
19.
Torres MJ, Padial A, Mayorga C, Fernandez T, Sanchez-Sabate E, Cornejo-Garcia JA, Antunez C, Blanca M: The diagnostic interpretation of basophil activation test in immediate allergic reactions to betalactams. Clin Exp Allergy 2004;34:1768-1775.
20.
Abuaf N, Rostane H, Rajoely B, Gaouar H, Autegarden JE, Leynadier F, Girot R: Comparison of two basophil activation markers CD63 and CD203c in the diagnosis of amoxicillin allergy. Clin Exp Allergy 2008;38:921-928.
21.
De Weck AL, Sanz ML, Gamboa PM, Aberer W, Blanca M, Correia S, Erdman S, Jermann JM, Kanny G, Kowalski M, Mayorga L, Medrala W, Merk A, Sturm GJ, Sainte-Laudy J, Schneider MS, Sczczeklik A, Weber JM, Wedi A: Nonsteroidal anti-inflammatory drug hypersensitivity syndrome. A multicenter study. I. Clinical findings and in vitro diagnosis. J Investig Allergol Clin Immunol 2009;19:355-369.
22.
Eberlein B, Leon S, Darsow IU, Rueff F, Behrendt H, Ring J: A new basophil activation test using CD63 and CCR3 in allergy to antibiotics. Clin Exp Allergy 2010;40:411-418.
23.
Garcia-Ortega P, Marin A: Usefulness of the basophil activation test (BAT) in the diagnosis of life-threatening drug anaphylaxis. Allergy 2010;65:1204-9995.
24.
Torres MJ, Ariza A, Fernandez J, Moreno E, Laguna JJ, Montanez MI, Ruiz-Sanchez AJ, Blanca M: Role of minor determinants of amoxicillin in the diagnosis of immediate allergic reactions to amoxicillin. Allergy 2010;65:590-596.
25.
Torres MJ, Romano A, Blanca-Lopez N, Dona I, Canto G, Ariza A, Aranda A, Montanez MI, Mayorga C, Blanca M: Immunoglobulin E-mediated hypersensitivity to amoxicillin: in vivo and in vitro comparative studies between an injectable therapeutic compound and a new commercial compound. Clin Exp Allergy 2011;41:1595-1601.
26.
Seitz CS, Brocker EB, Trautmann A: Diagnostic testing in suspected fluoroquinolone hypersensitivity. Clin Exp Allergy 2009;39:1738-1745.
27.
Lobera T, Audicana MT, Alarcon E, Longo N, Navarro B, Munoz D: Allergy to quinolones: low cross-reactivity to levofloxacin. J Investig Allergol Clin Immunol 2010;20:607-611.
28.
Ben SB, Berard F, Bienvenu J, Nicolas JF, Rozieres A: Usefulness of basophil activation tests for the diagnosis of IgE-mediated allergy to quinolones. Allergy 2010;65:535-536.
29.
Aranda A, Mayorga C, Ariza A, Dona I, Rosado A, Blanca-Lopez N, Andreu I, Torres MI: In vitro evaluation of IgE-mediated hypersensitivity reactions to quinolones. Allergy 2011;66:247-254.
30.
Rouzaire P, Nosbaum A, Denis L, Bienvenu F, Berard F, Cozon G, Bienvenu J: Negativity of the basophil activation test in quinolone hypersensitivity: a breakthrough for provocation test decision-making. Int Arch Allergy Immunol 2012;157:299-302.
31.
Gamboa PM, Sanz ML, Caballero MR, Antepara I, Urrutia I, Jauregui I, Gonzalez G, Dieguez I, De Weck AL: Use of CD63 expression as a marker of in vitro basophil activation and leukotriene determination in metamizol allergic patients. Allergy 2003;58:312-317.
32.
Sanz ML, Garcia MC, Caballero MR, Dieguez I, Gamboa PM: Basophil activation test in the diagnosis of allergy to medicines. An Sist Sanit Navar 2003;26(suppl 2):39-47.
33.
Gamboa P, Sanz ML, Caballero MR, Urrutia I, Antepara I, Esparza R, De Weck AL: The flow-cytometric determination of basophil activation induced by aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) is useful for in vitro diagnosis of the NSAID hypersensitivity syndrome. Clin Exp Allergy 2004;34:1448-1457.
34.
Malbran A, Yeyati E, Rey GL, Galassi N: Diclofenac induces basophil degranulation without increasing CD63 expression in sensitive patients. Clin Exp Immunol 2007;147:99-105.
35.
Rodriguez-Trabado A, Camara-Hijon C, Ramos-Cantarino A, Porcel-Carreno SL, Jimenez-Timon S, Pereira-Navarro G, Hernandez-Arbeiza FJ, Fernandez-Pereira L: Basophil activation test for the in vitro diagnosis of nonsteroidal anti-inflammatory drug hypersensitivity. Allergy Asthma Proc 2008;29:241-249.
36.
Gomez E, Blanca-Lopez N, Torres MJ, Requena G, Rondon C, Canto G, Blanca M, Mayorga C: Immunoglobulin E-mediated immediate allergic reactions to dipyrone: value of basophil activation test in the identification of patients. Clin Exp Allergy 2009;39:1217-1224.
37.
Bavbek S, Ikinciogullari A, Dursun AB, Guloglu D, Arikan M, Elhan AH, Misirligil Z: Upregulation of CD63 or CD203c alone or in combination is not sensitive in the diagnosis of nonsteroidal anti-inflammatory drug intolerance. Int Arch Allergy Immunol 2009;150:261-270.
38.
Celik GE, Schroeder JT, Hamilton RG, Saini SS, Adkinson NF: Effect of in vitro aspirin stimulation on basophils in patients with aspirin-exacerbated respiratory disease. Clin Exp Allergy 2009;39:1522-1531.
39.
Harrer A, Lang R, Grims R, Braitsch M, Hawranek T, Aberer W, Vogel L, Schmid W, Ferreira F, Himly M: Diclofenac hypersensitivity: antibody responses to the parent drug and relevant metabolites. PLoS One 2010;5:e13707.
40.
Korosec P, Mavsar N, Bajrovic N, Silar M, Mrhar A, Kosnik M: Basophil responsiveness and clinical picture of acetylsalicylic acid intolerance. Int Arch Allergy Immunol 2011;155:257-262.
41.
Kim MS, Cho YJ: Flow cytometry-assisted basophil activation test as a safe diagnostic tool for aspirin/NSAID hypersenstivity. Allergy Asthma Immunol Res 2012;4:137-142.
42.
Abuaf N, Rostane H, Barbara J, Toly-Ndour C, Gaouar H, Mathelier-Fusade P, Leynadier F, Frances C, Girot R: Comparison of CD63 upregulation induced by NSAIDs on basophils and monocytes in patients with NSAID hypersensitivity. J Allergy (Cairo) 2012;2012:580873.
43.
Couto M, Gaspar A, Piedade S, Arede C, Menezes M, Sousa MJ, Sousa G, Morais-Almeida M: IgE-mediated metamizol allergy and the usefulness of the cellular allergen stimulation test. Eur Ann Allergy Clin Immunol 2012;44:113-116.
44.
Hagau N, Longrois D, Petrisor C: Threshold for positivity and optimal dipyrone concentration in flow cytometry-assisted basophil activation test. Allergy Asthma Immunol Res 2013;5:383-388.
45.
Ariza A, Fernandez TD, Dona I, Aranda A, Blanca-Lopez N, Melendez L, Canto G, Blanca M, Torres MJ, Mayorga C: Basophil activation after nonsteroidal anti-inflammatory drugs stimulation in patients with immediate hypersensitivity reactions to these drugs. Cytometry A 2014;85:400-407.
46.
Trcka J, Schmidt C, Seitz CS, Brocker EB, Gross GE, Trautmann A: Anaphylaxis to iodinated contrast material: nonallergic hypersensitivity or IgE-mediated allergy? AJR Am J Roentgenol 2008;190:666-670.
47.
Pinnobphun P, Buranapraditkun S, Kampitak T, Hirankarn N, Klaewsongkram J: The diagnostic value of basophil activation test in patients with an immediate hypersensitivity reaction to radiocontrast media. Ann Allergy Asthma Immunol 2011;106:387-393.
48.
Salas M, Gomez F, Fernandez TD, Dona I, Aranda A, Ariza A, Blanca-Lopez N, Mayorga C, Blanca M, Torres MJ: Diagnosis of immediate hypersensitivity reactions to radiocontrast media. Allergy 2013;68:1203-1206.
49.
Ebo FH, Piel GC, Conraads V, Stevens WJ: IgE-mediated anaphylaxis after first intravenous infusion of cyclosporine. Ann Allergy Asthma Immunol 2001;87:243-245.
50.
Longo N, Gamboa PM, Gastaminza G, Audicana MT, Antepara I, Jauregui I, Sanz ML: Diagnosis of clavulanic acid allergy using basophil activation and leukotriene release by basophils. J Investig Allergol Clin Immunol 2008;18:473-475.
51.
Ebo DG, Bridts CH, Stevens WJ: IgE-mediated anaphylaxis from chlorhexidine: diagnostic possibilities. Contact Dermatitis 2006;55:301-302.
52.
Ebo DG, Wets RD, Spiessens TK, Bridts CH, Stevens WJ: Flow-assisted diagnosis of anaphylaxis to patent blue. Allergy 2005;60:703-704.
53.
Apostolou E, Deckert K, Puy R, Sandrini A, de Leon MP, Douglass JA, Rolland JM, O'hehir RE: Anaphylaxis to Gelofusine confirmed by in vitro basophil activation test: a case series. Anaesthesia 2006;61:264-268.
54.
Ebo DG, Schuerwegh A, Stevens WJ: Anaphylaxis to starch. Allergy 2000;55:1098-1099.
55.
Cop N, Uyttebroek AP, Sabato V, Bridts CH, De Clerck LS, Ebo DG: Flow cytometric analysis of drug-induced basophil histamine release. Cytometry B Clin Cytom 2015, Epub ahead of print.
56.
Leysen J, De Witte L, Sabato V, Faber M, Hagendorens M, Bridts C, De Clerck L, Ebo D: IgE-mediated allergy to pholcodine and cross-reactivity to neuromuscular blocking agents: lessons from flow cytometry. Cytometry B Clin Cytom 2013;84:65-70.
57.
Van Gasse AL, Hagendorens MM, Sabato V, Bridts CH, De Clerck LS, Ebo DG: IgE poppy seed and morphine: all that glitters is not gold. J Allergy Clin Immunol Pract 2014, Epub ahead of print.
58.
Blanca M, Romano A, Torres MJ, Fernandez J, Mayorga C, Rodriguez J, Demoly P, Bousquet PJ, Merk HF, Sanz ML, Ott H, Atanaskovic-Markovic M: Update on the evaluation of hypersensitivity reactions to betalactams. Allergy 2009;64:183-193.
59.
Jones SC, Budnitz DS, Sorbello A, Mehta H: US-based emergency department visits for fluoroquinolone-associated hypersensitivity reactions. Pharmacoepidemiol Drug Saf 2013;22:1099-1106.
60.
Baldo BA, Pham NG: Drug Allergy: Clinical Aspects, Diagnosis, Mechanisms, Structure-Activity Relationships. New York, Springer, 2013.
61.
Uyttebroek AP, Sabato V, Bridts CH, De Clerck LS, Ebo DG: Moxifloxacin hypersensitivity: uselessness of skin testing. J Allergy Clin Immunol Pract 2015;3:443-445.
62.
MacGlashan D Jr: Marked differences in the signaling requirements for expression of CD203c and CD11b versus CD63 expression and histamine release in human basophils. Int Arch Allergy Immunol 2012;159:243-252.
63.
MacGlashan DW Jr: Basophil activation testing. J Allergy Clin Immunol 2013;132:777-787.
64.
Song WJ, Chang JS: Recent applications of basophil activation tests in the diagnosis of drug hypersensitivity. Asia Pac Allergy 2013;3:266-280.
65.
Philipse E, Sabato V, Bridts C, De CL, Ebo D: Basophil activation in the diagnosis of life-threatening hypersensitivity reaction to iodinated contrast media: a case report. Acta Clin Belg 2013;68:140-142.
66.
Faber M, Sabato V, De WL, Van GA, Hagendorens MM, Leysen J, Bridts CH, De Clerck LS, Ebo DG: State of the art and perspectives in food allergy. I. Diagnosis. Curr Pharm Des 2014;20:954-963.
67.
Ebo DG, Van Vaerenbergh M, de Graaf DC, Bridts CH, De Clerck LS, Sabato V: In vitro diagnosis of hymenoptera venom allergy and further development of component resolved diagnostics. Exp Rev Clin Immunol 2014;10:375-384.
68.
Uyttebroek AP, Sabato V, Bridts CH, Ebo DG: In vitro diagnosis of immediate IgE-mediated drug hypersensitivity: warnings and (unmet) needs. Immunol Allergy Clin North Am 2014;34:681-689.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.